On January 06, Curis Inc. (CRIS) announced updated data from Phase ½ Study of CA-4948 and initial clinical data from Phase 1 Study of CI-8993.
Curis, Inc. (NASDAQ: CRIS), stock kicked off in pre-market session with a huge jump as it was trading 141.3% to $3.55 after a biotechnology company
NanoVibronix Inc. (NASDAQ: NAOV) shares are trading down -4.55% at $1.05 at the time of writing after announcing $6.0 million private placement. Company’s 52-week ranged
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.